We are live on
!
Find out more
MIM
Meros Investment Management Portfolio holdings
AUM
$231M
1-Year Est. Return
35.94%
This Fund
S&P 500
This Quarter
Est. Return
-12.98%
1 Year Est. Return
+35.94%
3 Year Est. Return
+52.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$108M
AUM Growth
-$18.5M
(-15%)
Cap. Flow
+$818K
Cap. Flow
% of AUM
0.76%
Top 10 Holdings %
Top 10 Hldgs %
47.99%
Holding
38
New
3
Increased
24
Reduced
8
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BRY
Berry Corp
BRY
|
+$3.49M |
| 2 |
PLYM
Plymouth Industrial REIT
PLYM
|
+$2.82M |
| 3 |
BioLife Solutions
BLFS
|
+$2.2M |
| 4 |
QCR Holdings
QCRH
|
+$1.92M |
| 5 |
Cerence
CRNC
|
+$1.43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IIN
IntriCon Corporation
IIN
|
+$7.59M |
| 2 |
VIVO
Meridian Bioscience Inc
VIVO
|
+$3.24M |
| 3 |
Photronics
PLAB
|
+$1.82M |
| 4 |
LiqTech
LIQT
|
+$1.17M |
| 5 |
TREC
Trecora Resources
TREC
|
+$819K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 22.39% |
| 2 | Technology | 21.18% |
| 3 | Healthcare | 20.2% |
| 4 | Consumer Discretionary | 13.07% |
| 5 | Materials | 6.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PLYM
26
DELISTED
Plymouth Industrial REIT
PLYM
| $2.29M | 2.12% |
+130,346
| New | +$2.82M |
|
27
Harvard Bioscience
HBIO
$29.2M
| $2.24M | 2.08% |
62,198
+9,639
| +18% | +$435K |
|
28
Northern Technologies International Corp
NTIC
$80M
| $1.94M | 1.8% |
207,029
+550
| +0.3% | +$6.04K |
|
|
29
QCR Holdings
QCRH
$1.7B
| $1.9M | 1.76% |
+35,137
| New | +$1.92M |
|
30
Red Violet
RDVT
$924M
| $1.64M | 1.52% |
86,071
+226
| +0.3% | +$5.56K |
|
|
TEAD
31
Teads Holding Co
TEAD
$67.7M
| $1.44M | 1.34% |
287,056
+20,721
| +8% | +$156K |
|
32
Energy Recovery
ERII
$443M
| $900K | 0.83% |
46,345
+121
| +0.3% | +$2.35K |
|
|
CTHR
33
DELISTED
Charles & Colvard Ltd
CTHR
| $774K | 0.72% |
63,428
+167
| +0.3% | +$2.35K |
|
34
KORU Medical Systems
KRMD
$164M
| $747K | 0.69% |
295,065
+779
| +0.3% | +$1.89K |
|
35
MGP Ingredients
MGPI
$375M
| $312K | 0.29% |
3,119
-4,480
| -59% | -$421K |
|
|
36
LiqTech
LIQT
$21M
| – | – |
-59,619
| Closed | -$1.17M |
|
|
TREC
37
DELISTED
Trecora Resources
TREC
| – | – |
-96,924
| Closed | -$819K |
|
|
IIN
38
DELISTED
IntriCon Corporation
IIN
| – | – |
-318,160
| Closed | -$7.59M |
|
Similar funds
YCM
PWA
RF
CBOA
WF
SM
TRIA
TW
Meros Investment Management's Q2 2022 Portfolio in Review
As of Q2 2022, Meros Investment Management held 38 positions worth $108M, down 15% from $126M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Meros Investment Management's Q2 2022 filing shows 3 new, 24 increased, 8 reduced and 3 closed positions. Its largest new stake was Berry Corp: 330,716 shares worth $2.52M. The largest sale was IntriCon Corporation, an estimated $7.59M.
By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 21% a quarter earlier, followed by Technology and Healthcare.
- Meros Investment Management's largest Q2 2022 buy was Berry Corp: 330,716 shares worth $2.52M.
- Meros Investment Management added most to BioLife Solutions in Q2 2022, an estimated $2.2M increase.
- Meros Investment Management's biggest Q2 2022 reduction was Meridian Bioscience Inc, cutting an estimated $3.24M.
- Meros Investment Management fully exited IntriCon Corporation in Q2 2022, selling an estimated $7.59M.
- Meros Investment Management's ten largest holdings make up 48% of its $108M portfolio in Q2 2022.
- Meros Investment Management opened 3 new positions and closed 3 in Q2 2022.
- Meros Investment Management's portfolio value fell 15% quarter-over-quarter to $108M.
Based on Meros Investment Management's 13F filing for Q2 2022, filed 12 Aug 2022.